References: |
LSN3154567 is a novel inhibitor of NAMPT with IC50 of 18 nM (NCI-H1155 cell), 49 nM (Calu-6 cell), 333 nM (HCC1937 cell), and 389 nM (MCF-7 cell), respectively. IC50 value: 18 nM (NCI-H1155 cell), 49 nM (Calu-6 cell), 333 nM (HCC1937 cell), 389 nM (MCF-7 cell) Target: NAMPT LSN3154567 is a novel pyridyloxyacetyl tetrahydroisoquinoline compounds that inhibit activity of nicotinamide phosphoribosyltransferase (NAMPT), pharmaceutical to treat physiological disorders, more particularly for the treatment of cancer. |